Search

Search Results

• Temporal Changes in Lung Cancer: A 10-year Study in a Chest Hospital

  H. Halilcolar, S. Yapicioglu, S. Bilaceroglu

  2016-01-26

  Published: January 26, 2016

  574

  PDF: 469
• 

  Can serum progranulin level be used as a prognostic biomarker in non-small cell lung cancer?

  Nevin Taci Hoca, Ebru Ünsal, Koza Murat, Arzu Ertürk, Nermin Çapan

  2022-11-14

  Published: November 14, 2022

  864

  PDF: 187

• Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study

  T. Berghmans, A-P Meert, V. Ninane, J-P Sculier

  2005-12-30

  Published: December 30, 2005

  792

  PDF: 409

• Weekly chemotherapy with cisplatin and paclitaxel in advanced NSCLC: a phase II study

  G. Buccheri, D. Ferrigno, M.C. Giordano

  2016-02-15

  Published: February 15, 2016

  609

  PDF: 443
• 

  Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report

  Paola Maria Medusa , Marina Gilli, Luca Notizia, Raffaella Pagliaro, Nicola Carro, Alessandro Moriello, Vito D'Agnano, Andrea Bianco, Fabio Perrotta, Fabiana Vitiello

  2022-11-25

  Published: November 25, 2022

  1183

  PDF: 301

• The usefulness of transesophageal echocardiography in the staging of locally advanced lung cancer

  U. Caterino, G. Dialetto, F.E. Covino, G. Mazzarella, E. Grella, M. Massimo

  2016-02-03

  Published: February 3, 2016

  528

  PDF: 482
• 

  Statistical approach to mediastinal staging in NSCLC with M.E.S.S.i.a. software

  Thomas Galasso, Lorenzo Corbetta, Laura Mancino, Lucio Michieletto, Loris Ceron

  2019-09-10

  Published: September 10, 2019

  1212

  PDF: 668

• Pulmonary Rehabilitation in lung cancer

  F. Pasqua, K. Geraneo, I. Nardi, F. Lococo, A. Cesario

  2015-11-25

  Published: November 25, 2015

  2327

  PDF: 1457
• 

  ROS1 positive non-small cell lung cancer with pulmonary embolism in a 22-year woman

  Ananda Datta, Satya Padmaja Mantha, Suvradeep Mitra, Prasanta Raghab Mohapatra, M Srikanth Goud, Manoj Kumar Panigrahi

  2020-08-07

  Published: August 7, 2020

  697

  PDF: 488
• 

  Non-small cell lung cancer presenting as "psoas muscle syndrome": a case report

  Mariano Mollica, Rosalba Maffucci, Sabrina Lavoretano, Gaetano Rea, Francesco Saverio Cerqua, Luigi Aronne, Andrea Bianco, Fabio Perrotta

  2019-04-05

  Published: April 5, 2019

  1641

  PDF: 1029

• Common epidermal growth factor receptor mutations in north Indian patients with non-small cell lung carcinoma: evidence from real-time polymerase chain reaction

  Rakesh Behera, Sheetal Arora, Pranav Ish, Geetika Khanna

  2024-10-25

  Published: October 25, 2024

  578

  PDF_EARLY VIEW: 60

• Survival among patients with lung cancer managed at a tertiary care center in North India

  Rahul Kumar, Dipti Gothi, Shweta Anand, Shazia Khan, Nipun Malhotra

  2024-07-26

  Published: July 26, 2024

  315

  PDF_EARLY VIEW: 194
• 

  Detection of clinically-relevant EGFR variations in de novo small cell lung carcinoma by droplet digital PCR

  Rajesh Venkataram, Vijith Shetty, Kishan Prasad, Sonam Kille, Teerthanath Srinivas, Anirban Chakraborty

  2022-09-02

  Published: September 2, 2022

  1000

  PDF: 406
• 

  Quantitative analysis of cell-free DNA by droplet digital PCR reveals the presence of EGFR mutations in non-malignant lung pathologies

  Rajesh Venkataram, Srividya Arjuna, Giridhar Belur Hosmane, Anirban Chakraborty

  2021-05-04

  Published: May 4, 2021

  1506

  PDF: 579
• 

  Alectinib rescue therapy in advanced ALK rearranged lung adenocarcinoma: a case report

  Cristiano Cesaro, Umberto Caterino, Fabio Perrotta, Umberto Masi, Alessandra Cotroneo, Roberta Cianci, Enzo Zamparelli, Flavio Cesaro, Dario Amore, Danilo Rocco

  2022-09-20

  Published: September 20, 2022

  1112

  PDF: 218
• 

  Interstitial nephritis secondary to treatment with pembrolizumab, a rare complication in two patients with lung adenocarcinoma

  Diana Alexandra Gonçalves Pimenta, Renata Carvalho, Raquel Pereira, Rui Rolo, Lurdes Ferreira

  2022-07-28

  Published: July 28, 2022

  940

  PDF: 361
• 

  Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India

  Ritu Kulshrestha, Himanshi Saxena, Raj Kumar, Sonam Spalgais, Parul Mrigpuri, Nitin Goel, Balakrishnan Menon, Meenu Rani, Pawan Mahor, Ishita Bhutani

  2023-02-01

  Published: February 1, 2023

  1110

  PDF: 302